RARA CRAFT DATABASE for FDA Medical Devices
510(k)K211722

FDA DEVICE FACTS

Laser treatment system , models Nyx plus, Grace plus, Nemesis, Ares

Canadian Pioneer Medical Technology Corporation

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEFebruary 25, 2022PRODUCT CODEGEX

Indications for use

The indication of use of 3 wavelength 755,808,1064 handpiece (trio is treatment of Benign vascular lesions and vascular dependent lesions removal The indication of use of trio is treatment of Benign vascular lesions and vascular dependent lesions removal Laser classification Class IV Class IV Wavelength The Simultaneous triple-wavelength laser device (trio) 755-808-1064 nm Trio 755-808-1064 nm Frequency 1-10Hz 0.5~3 Hz (HR), 5~10 Hz(SHR); 2 Hz(LB) Pulse Duration 5-300 (to 400 optional) 3.3-200ms Biocompatib ility Comply with ISO10993-1 Comply with ISO10993-1 Electrical Safety Comply with IEC60601-1, IEC60601-2-22 Comply with IEC60601-1, IEC60601-2-22 EMC Comply with IEC60601-1-2, Comply with IEC60601-1-2, Laser safety Comply with IEC60825-1, IEC60601-2-22 Comply with IEC60825-1, IEC60601-2-22

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 23, 2026